Patients who previously underwent LASIK and are now experiencing age-related vision changes have a new path forward. In its ...

Bausch + Lomb is building out its portfolio of intraocular lenses for people with cataracts, with the acquisition of AcuFocus and its replacement implant designed to offer an extended depth of field.

ReVision Optics Inc., a Lake Forest eye device maker with $35 million in fresh funding, plans to start a U.S. clinical trial and prepare for sales in Europe. The company makes the Presbylens corneal ...